
Virupaksha Organics Ltd. has emerged as a leader in the pharmaceutical industry, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs). Founded in 2003, the company has built a reputation for innovation, quality, and sustainability. Under the dynamic leadership of Mr. Chandra Mouliswar Reddy Gangavaram, Virupaksha has grown its operations significantly, with state-of-the-art manufacturing facilities in Telangana, India.
The company’s facilities in Kazipally and Pashamylaram are certified by international and national regulatory bodies, including ISO 9001, ISO 14001, ISO 45001, ISO 50001, and GMP standards, ensuring that Virupaksha meets the highest levels of quality and safety in its production processes. These certifications highlight the company’s commitment to environmental sustainability, occupational safety, and best industry practices.
Virupaksha Organics is committed to excellence, innovation, and customer satisfaction, with a focus on developing sustainable solutions for the pharmaceutical industry. The company’s products are trusted by major pharmaceutical firms globally, as it continues to make strides towards becoming a research-driven organization. With a forward-thinking management team and a clear vision for the future, Virupaksha Organics is poised for rapid growth and continues to play a key role in advancing global healthcare.
As part of its corporate social responsibility (CSR), Virupaksha has initiated numerous welfare programs aimed at uplifting local communities and supporting environmental conservation, reinforcing its reputation as a responsible corporate citizen.
With continuous advancements and strategic partnerships, Virupaksha Organics Ltd. is well-positioned to expand its global footprint and contribute to the evolving pharmaceutical landscape.

Other Latest News
- Anti-Israel students conspire to smear law firms critical of antisemitism, report finds Fox News Students and staff at Harvard University deliberate the school's loss of funding amid its battle with the Trump administration. Anti-Israel law students at Harvard conspired to smear numerous law firms that have stood opposed to anti-Israel efforts on …
- How affirmative action ruling, federal funding cuts impact pharma and biotech Medical Marketing and Media It’s been nearly 18 months since the Supreme Court struck down the use of affirmative action in college admissions and the impact of that decision is being felt by the healthcare industry. Data released by the Association of American Medical Colleges …
- STAT+: How to think about Trump’s pharma tariffs — before they hit STAT - Massachusetts For weeks, President Trump has made it clear that tariffs are going to be slapped on pharmaceuticals. But that is about the only thing that is clear. For the moment, his administration has opened a formal investigation that would determine the extent to …
- STAT+: Pharmalittle: We’re reading about FDA layoffs hurting user fee programs, pharma tariffs, and more STAT - Massachusetts And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We expect to promenade with the official mascots and catch up …
- ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot Benzinga Three healthcare-themed ETFs were in sharp spotlight Thursday as the sector got through a wild trading day, fueled by UnitedHealth’s UNH earnings disappointment and steep stock decline. While insurers weighed down on broad healthcare gauges, a drugmakers …
- Pharma Fridays – April 18, 2025 Endocrine News An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * On April 15, Recordati announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for ISTURISA …
- Rigaku and SPERA PHARMA Partner to Advance Pharmaceutical Development American Pharmaceutical Review Rigaku Corporation and SPERA PHARMA have initiated a strategic partnership aimed at accelerating and transforming pharmaceutical development by leveraging the two companies’ cutting-edge technologies and extensive expertise. SPERA PHARMA will use XtaLAB …
- Companies announce presentations at upcoming 2025 ARVO Annual Meeting Ophthalmology Times The 2025 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting will take place May 4-8, 2025, in Salt Lake City, Utah. Ahead of this exciting meeting, several companies have announced that data from clinical trials will be shared at …
- Fierce Pharma Asia—The latest on Trump's tariffs; Leqembi's EU approval; Kyowa Kirin's biologics plant Fierce Pharma The Trump administration is expected to announce tariffs on pharmaceuticals "in the next month or two," an official said. The European Commission has approved Eisai and Biogen's Leqembi in Alzheimer's disease. Kyowa Kirin has finished the …
- RFK Jr.'s FDA staff cuts claimed key user fee negotiators, threatening renewal talks with pharma: Reuters Fierce Pharma As the prospect of sector-specific tariffs under the second Trump administration continues to rattle drugmakers, a more fundamental threat to the U.S. biopharma industry is reportedly playing out in the offices of the nation’s drug regulator. The recent …
- FDA drug reauthorization process muddled after pharma fee negotiators laid off The Gazette - Colorado Like much of the federal government, the Food and Drug Administration has faced several program cuts and changes under the Trump administration’s sweeping changes to the bureaucracy. In the most recent round of cuts, various senior negotiators at the FDA …
- Pharma Pulse 4/18/25: Bringing Biotech Innovation Across Borders, Role of Collaboration in Advancing Rare Disease Research Pharmaceutical Commerce Bringing Biotech Innovation Across Borders A feature published by Pharmaceutical Executive authored by Ed Ahn, CEO of MEDIPOST, Inc, outlines four tips for midsized companies when entering new global markets. The Role of Collaboration in Advancing Rare …
- Pharmaceutical Executive® announces submissions now open for the 2025 APEX Awards honoring excellence in pharmaceutical marketing EIN Presswire CRANBURY, NJ, April 18, 2025 (GLOBE NEWSWIRE) -- It’s time to embody excellence in advertising. Pharmaceutical Executive® is pleased to announce that submissions are now open for the 2025 Pharmaceutical Executive APEX Awards. When Pharmaceutical Executive …
- 'Pathetic': It's Ukrainian Embassy Vs Russian Embassy Over Indian Pharma Warehouse Fire In Kyiv News18 Last Updated:April 18, 2025, 13:09 IST Russia had blamed Ukraine's air defence missile for the fire at Indian pharma warehouse in Kyiv and said that the incident did not take place due to a direct Russian strike. Ukraine's President Volodymyr …
- Five things for pharma marketers to know: Friday, April 18, 2025 Medical Marketing and Media U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs would likely be absorbed by drugmakers rather than patients whose payments are often set by health insurance. U.S. health insurers, …
- Business News | BigBloc Construction Ltd: Building the Future as India's AAC Block Trailblazer Latestly PNN New Delhi [India], April 18: Incorporated in 2015, BigBloc Construction Ltd is one of the largest and only listed AAC block manufacturer in India, with a 1.3 million cubic meter per annual capacity across plants in Gujarat (Kheda, Umargaon, Kapadvanj) …
- Russian Embassy Denies Airstrike On Indian Pharma Warehouse In Kyiv, Blames Ukraine For Attack MENAFN (MENAFN- IANS) Moscow, April 18 (IANS) The Russian Embassy in India has dismissed the claims made by Ukraine that it attacked Indian pharmaceutical company Kusum, calling the news fake. It instead accused the war-torn nation (Ukraine) of attacking the …
- Russia Embassy Denies Strike on Indian Pharma Warehouse in Kyiv, Blames Ukrainian Missile Latestly Moscow, April 18: Russia on Thursday dismissed Ukraine's accusation that its military attacked the warehouse of an Indian pharmaceutical company in Kyiv. The Russian Embassy in India suggested that it was likely one of Ukraine's own air defence …
- Biomednewsbreaks - Kairos Pharma Ltd. (NYSE American: KAPA) Secures Dod Grant To Advance Lung Cancer Biomarker Research MENAFN (MENAFN- Investor Brand Network) Kairos Pharma (NYSE American: KAPA) announced that the U.S. Department of Defense has awarded $876,000 to Cedars-Sinai Medical Center to support biomarker research for Kairos' Phase 1 trial of ENV105 in EGFR-driven non- …
- Pharma Pulse 4/17/25: Pharma Companies Expected to Absorb Any Tariff Hit in Short Term, New Chronic Antigen Exposure Data, & more Pharmaceutical Commerce Pharma companies expected to absorb any tariff hit in short term While US tariffs on pharmaceuticals may eventually raise drug prices, especially for generics, experts say brand-name costs will likely be absorbed by manufacturers in the short term— …
- Top gainers & losers today, 17 Apr: Eternal, ICICI Bank, Bharti Airtel, Sun Pharma, SBI, Tech Mahindra The Hindu Business Line Markets rallied for the fourth consecutive session on Thursday, with the BSE Sensex surging 1,508.91 points or 1.96 per cent to close at a record high of 78,553.20. The NSE Nifty 50 jumped 414.45 points or 1.77 per cent to finish at 23,851.65. This …
- Russia Blames Ukrainian Air Defence For Fire At Indian Pharma Company's Warehouse In Kyiv News18 Last Updated:April 17, 2025, 20:44 IST Russia claims the fire at Kusum Pharma warehouse in Kyiv was caused by a Ukrainian air defence missile, not a Russian strike, contrary to Kyiv authorities and the British envoy's allegations. An image shared by …
- India News | Russia Rejects Ukraine's Charges That Russian Military Attacked Indian Firm's Warehouse in Kyiv Latestly New Delhi, Apr 17 (PTI) Russia on Thursday trashed Ukraine's allegations that the Russian military attacked a warehouse of an Indian pharmaceutical company in Kyiv. The Russian embassy suggested that the Ukrainian air defence missiles may have fallen …
- Big pharma pushes for European policy change as tariffs loom Pharmaceutical Technology Pharmaceutical companies are demanding changes in European regulation as looming tariffs implemented by US President Donald Trump “threaten” billions of planned pharma investments on the continent. A group of 32 pharma companies sent a letter to European …
- Five things for pharma marketers to know: Thursday, April 17, 2025 Medical Marketing and Media An internal budget document leaked to the press gave the clearest vision yet of HHS Secretary Robert F. Kennedy Jr.’s planned chronic disease-fighting agency: the Administration for a Healthy America. The Office of Management and Budget document, which …
- Daily News Wrap-Up: IEX Proposes Real-Time Green Energy Trading Mercom India The Central Electricity Regulatory Commission invited stakeholder feedback by April 23, 2025, on a proposal by the Indian Energy Exchange (IEX) to introduce real-time trading in renewable energy. Considering that IEX could not meet the significant demand …
- Mira Pharma Leads Healthcare Buzz Surge On Promising Oral Ketamine Analog Preclinical Trial myMotherLode The drug outperformed standard treatments like pregabalin and gabapentin in prior studies and has shown a favorable safety profile without ketamine's psychedelic effects. Shares of Mira Pharmaceuticals gained over 19% on Wednesday, marking their best …
- Ipsos : Un 1er trimestre conforme aux attentes dans un environnement volatil EIN Presswire Un 1er trimestre conforme aux attentes dans un environnement volatil Paris, 17 avril 2025 – Ipsos, l’une des principales sociétés mondiales d’études de marché, a réalisé un chiffre d’affaires de 568,5 millions d’euros au premier trimestre 2025. La …
- Ipsos: A first quarter in line with expectations in a volatile environment EIN Presswire A first quarter in line with expectations in a volatile environment Paris, April 17, 2025 - Ipsos, one of the world's leading market research companies, achieved a revenue of 568.5 million euros in the first quarter 2025. Growth stands at 2.0%, …
- Stocks to watch: From Wipro, Infosys, Paytm to UltraTech Cement; List of 11 stocks in news today Financial Express From quarterly results to big deals and legal updates, several companies are in focus today. On April 16, Indian equity benchmarks ended on a strong note, with the Sensex climbing 309.40 points to close at 77,044.29 and the Nifty advancing 108.65 points to …
- STAT+: Pharmalittle: We’re reading about Trump order targeting drug prices, pharma seeking EU help, and more STAT - Massachusetts Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far so we are determined to hang on for another couple of days. And why not? The alternatives — …
- Podcast: What’s next for the pharma tariffs? Pharmaceutical Technology The US government has signalled a major shift in its trade policies in recent weeks, with several announcements detailing plans for import tariffs. While President Trump has made several announcements on tariffs since he took office, things accelerated on …
- Non-Profit AI Consortium Adds Pharma Companies American Pharmaceutical Review OpenFold, a non-profit AI research consortium dedicated to creating free, open-source software tools for biology and drug discovery, announced today eight new industry partners. Joining the consortium are Bristol Myers Squibb, COGNANO, Lambda, Novo Nordisk …
- Meribel Pharma Solutions Joins the CDMO Marketplace Pharmaceutical Commerce There is a new contract development and manufacturing organization (CDMO) in the marketplace. With the ultimate goal of boosting patient health through its manufacturing services, Meribel Pharma Solutions has officially launched, bringing with it a …
- Global adspend on news brands forecast to decline by a third Campaign Asia Global adspend on news brands is expected to fall to $32.3 billion in 2025, according to WARC’s latest Global Advertising Trends report, which would be indicative of a 33.1% decrease from 2019. The outlook for 2026 is spending will remain flat, with WARC …
- UPDATE: With looming Trump tariffs, pharma companies demand changes to stay in EU Fierce Pharma Pharma companies are leveraging the United States’ threat of tariffs on drug imports to push for policy changes in the EU. In a letter sent to European Commission President Ursula von der Leyen, 32 pharma companies demanded more favorable policies in order …
- Trump throws pharma 'bread crumb' concession with call to end IRA pill penalty Fierce Pharma As tariff threats and FDA staff cuts thrust the biopharma world into uncharted waters, President Donald Trump is offering the industry some reprieve by ordering the elimination of the so-called "pill penalty" baked into 2022’s Inflation Reduction …
- Johnson & Johnson's Q1 Results, FY Guidance Highlight The 'Power Of The Pharma Portfolio' Benzinga Johnson & Johnson JNJ reported upbeat first-quarter results on Wednesday. Here are some key analyst takeaways. Goldman Sachs On Johnson & Johnson Analyst Asad Haider maintained a Buy rating and price target of $172. Despite Stelara sales declining …
- Billionaire Mark Cuban Says 'Pharma Is the Easiest Business I've Ever Disrupted' — In a $500 Billion Industry, '1% Is A Whole Lot Of Money' Benzinga Let's be honest — nobody's walking around bragging about how great the U.S. healthcare system is. From surprise bills to mystery charges and sky-high prescription prices, it's a mess. And while most people just grit their teeth and deal with it …
- Breakfast News: ASML Orders Disappoint The Motley Fool USA Chipmaker falls, tariff negotiations, Alphabet lawsuit, and more... Breakfast News: ASML Orders Disappoint April 16, 2025 Wednesday's Markets S&P 500 5,397 (-0.17%) Nasdaq 16,823 (-0.05%) Dow 40,571 (-0.01%) Bitcoin $83,891 (-1.98%) Source: Image …
- This UroGen Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday Benzinga Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Scotiabank analyst Allan Verkhovski initiated …
- US targets tariffs on computer chips, pharma The Antelope Valley Press - California BANGKOK — The Trump administration has taken its next steps toward imposing more tariffs on key imports, launching investigations into imports of computer chips, chip making equipment and pharmaceuticals. The Department of Commerce posted notices about …
- ‘Finally, Some Good News’: Trump Signals Support for Removing IRA’s Pill Penalty BioSpace President Donald Trump issued an executive order on Tuesday to “improve” the drug price negotiation program under the Inflation Reduction Act, with the goal of lowering the prices of prescription drugs. Analysts across the board lauded the move, …
- Trump pharma tariff threat raises specter of shortages, price hikes WFLA - Florida The pharmaceutical industry is bracing for chaos if President Trump follows through on his threat to impose “a major tariff” on prescription drug imports. Tariffs would disrupt international supply chains, force companies to decide whether to pass …
- Meet Nandini Piramal, Oxford Graduate, Isha Ambani's Sister-In-Law, Chairperson Of Piramal Pharma Bollywood Shaadis Asia’s richest man, Mukesh Ambani’s daughter, Isha Ambani, has been married to Anand Piramal since 2018. The couple has twins: a daughter, Aadiya, and a son, Krishna. Anand, son of industrialist, Ajay Piramal and Dr. Swati Piramal, is the heir to the …
- In major development in pharma, halt order enforced on production and sale of 35 fixed-dose combination drugs ETManufacturing.in This has led to inconsistent enforcement of the NDCT Rules 2019 across the nation, as pointed out in the letter.The Central Drugs Standard Control Organisation (CDSCO), the apex regulatory authority for pharmaceuticals in India, has mandated that drug …
- UK Front Pages 16/04: Tariffs, Political Clashes, and Trade Balancing Acts Dominate News London Daily Digital The world stage is abuzz with a series of high-stakes developments that are reshaping industries, political landscapes, and international relations. The Times reports on the urgent scramble by US officials to mitigate the impact of potential tariffs on the …
- Five things for pharma marketers: Wednesday, April 16, 2025 Medical Marketing and Media Tariff wars between the U.S. and China will impact popular U.S. made drugs in China, according to regulatory data. China announced that it will raise levies on U.S. imported goods to 125%. (Reuters) The first vaccine advisory committee at the Centers for …
- Business News | India's Will Have a Bi-lateral Trade Agreement with US in Next Few Months: Morgan Stanley Latestly New Delhi [India], April 16 (ANI): India's potential trade deal with the US may take time, but it is more likely to happen in the next few months, and it could help India gain a share in the US market. However, a report by Morgan Stanley says elevated …
- Is Ascendis Pharma A/S (ASND) the Best Growth Stock to Buy According to Billionaires? Yahoo Finance We recently published a list of 10 Best Growth Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Ascendis Pharma A/S (NASDAQ:ASND) stands against other best growth stocks to buy according to billionaires. …